122. Dalbavancin Use in Patients with Substance Use Disorders

BACKGROUND: Dalbavancin, a lipoglycopeptide antibiotic, has an extended half-life that allows for weekly dosing and is an alternative to daily intravenous (IV) antibiotics. The dosing interval has the potential to expand treatment options for more severe infections in patients with substance use dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Streifel, Amber C, Makadia, Jina, Luke, Strnad, Douglass, Alyse, Mayer, Heather, Young, Kathleen, Lewis, James, Sukerman, Ellie, Sikka, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777264/
http://dx.doi.org/10.1093/ofid/ofaa439.432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777264/
http://dx.doi.org/10.1093/ofid/ofaa439.432

Ejemplares similares